id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-D-1146-0041,FDA,FDA-2021-D-1146,"Real-World Data: Assessing Registries to Support Regulatory Decision-Making for Drug and Biological Products;
Guidance for Industry; Draft Guidance",Other,Guidance,2023-12-22T05:00:00Z,2023,12,2023-12-22T05:00:00Z,,2023-12-22T13:19:31Z,,0,0,090000648634c2e0
FDA-2021-D-1146-0043,FDA,FDA-2021-D-1146,"Real-World Data: Assessing Registries to Support Regulatory Decision-Making for Drug and Biological Products;
Guidance for Industry; Final Guidance",Other,Guidance,2023-12-22T05:00:00Z,2023,12,2023-12-22T05:00:00Z,,2024-11-12T06:22:12Z,,1,0,090000648634c300
FDA-2021-D-1146-0042,FDA,FDA-2021-D-1146,Real-World Data: Assessing Registries To Support Regulatory Decision-Making for Drug and Biological Products; Guidance for Industry; Availability,Notice,Notice of Availability,2023-12-22T05:00:00Z,2023,12,,,2023-12-22T15:24:04Z,2023-28289,0,0,090000648635117e
FDA-2021-D-1146-0001,FDA,FDA-2021-D-1146,"Real-World Data: Assessing Registries To Support Regulatory Decision-Making for Drug and Biological
Products; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2021-11-30T05:00:00Z,2021,11,2021-11-30T05:00:00Z,2022-03-01T04:59:59Z,2022-03-02T02:00:49Z,2021-26006,0,0,0900006484e8bbad